Elfriede Pahl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elfriede Pahl has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
A. Lal
Cardiology, Primary Children’s Hospital, Salt Lake City, UT
1 shared publicationBrett M. Mitchell
Departments of Pediatrics and Medicine, Northwestern University Medical School, Chicago, Illinois, USA
1 shared publicationC.E. Canter
Cardiology, Washington University, St. Louis, MO
1 shared publicationCatherine L. Webb
Divisions of Cardiology and Infectious Disease, Department of Pediatrics (E.P., D.C., C.L.W., S.T.T.), The Children's Memorial Hospital and the Department of Medicine (F.C.), Northwestern University Medical School, Chicago, Il
1 shared publicationCharles E Canter
1 shared publicationD. Dodd
Cardiology, Vanderbilt University, Nashville, TN
1 shared publication
Latest Publications
- 1 April 2016
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 35 (4) , S158-S159
Utilization and Safety of Long-Term Carvedilol in Pediatric Dilated Cardiomyopathy: A Multicenter Study from the Pediatric Cardiomyopathy Registry
- 1 April 2016
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 35 (4) , S158-S159
Utilization and Safety of Long-Term Carvedilol in Pediatric Dilated Cardiomyopathy: A Multicenter Study from the Pediatric Cardiomyopathy Registry
- 1 March 2001
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 20 (3) , 279-287
Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: a multi-institutional study
- 1 March 2001
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 20 (3) , 279-287
Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: a multi-institutional study
- 1 November 2000
- Published by Wiley in Pediatric Transplantation
- Vol. 4 (4) , 268-272
Impaired exercise parameters in pediatric heart transplant recipients: Comparison of biatrial and bicaval techniques
The exercise performance of pediatric heart transplant recipients and the effects of bicaval anastomosis were studied in 19 children using a Bruce protocol. Although all children had decreased exercise capacity and heart rates when compared with normals, the bicaval anastomosis patients had similar endurance and peak heart rates as the standard biatrial group.
- 1 November 2000
- Published by Wiley in Pediatric Transplantation
- Vol. 4 (4) , 268-272
Impaired exercise parameters in pediatric heart transplant recipients: Comparison of biatrial and bicaval techniques
The exercise performance of pediatric heart transplant recipients and the effects of bicaval anastomosis were studied in 19 children using a Bruce protocol. Although all children had decreased exercise capacity and heart rates when compared with normals, the bicaval anastomosis patients had similar endurance and peak heart rates as the standard biatrial group.
- 1 January 1997
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 7 (1) , 56-62
The feasibility of high-dose dobutamine stress echocardiography in children
We recently reported our experience with exercise stress echocardiography in children with prior history of Kawasaki disease and coronary arterial involvement. Dobutamine stress echocardiography has been used in adults (doses up to 50 μg/kg/min) for diagnosis and risk stratification of coronary arterial disease. To date, no studies have assessed the safety and utility of high-dose dobutamine for the detection of abnormalities of wall motion in children, although low dose dobutamine (5 μg/kg/min) has been used to assess left ventricular function after use of anthracycline in children. Our study group consisted of 10 children known to have Kawasaki disease, and 16 children who had undergone heart transplantation. After baseline transthoracic echocardiographic imaging, dobutamine was infused in an incremental fashion, 10–40 μg/kg/min intravenously, to attain peak heart rate. Heart rate and blood pressure were monitored continuously, and 4 standard echocardiographic images were acquired at each stage of dobutamine infusion and at recovery. Images were digitized, and the left ventricular segments were reviewed to assess wall motion. No patients suffered serious side effects such as arrhythmias or hypotension. Studies were complete in all 26 patients. One study proved positive, with a new abnormality of wall motion identified corresponding to a critical right coronary arterial stenosis. Peak heart rate and blood pressure were similar for the 2 groups. High dose dobutamine stress echocardiography, therefore, is feasible and safe in children, and may detect flow-limiting coronary arterial stenoses noninvasively. The technique may safely be applied to other subsets of children where assessment of ischemia and contractile reserve is warranted.
- 1 January 1997
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 7 (1) , 56-62
The feasibility of high-dose dobutamine stress echocardiography in children
We recently reported our experience with exercise stress echocardiography in children with prior history of Kawasaki disease and coronary arterial involvement. Dobutamine stress echocardiography has been used in adults (doses up to 50 μg/kg/min) for diagnosis and risk stratification of coronary arterial disease. To date, no studies have assessed the safety and utility of high-dose dobutamine for the detection of abnormalities of wall motion in children, although low dose dobutamine (5 μg/kg/min) has been used to assess left ventricular function after use of anthracycline in children. Our study group consisted of 10 children known to have Kawasaki disease, and 16 children who had undergone heart transplantation. After baseline transthoracic echocardiographic imaging, dobutamine was infused in an incremental fashion, 10–40 μg/kg/min intravenously, to attain peak heart rate. Heart rate and blood pressure were monitored continuously, and 4 standard echocardiographic images were acquired at each stage of dobutamine infusion and at recovery. Images were digitized, and the left ventricular segments were reviewed to assess wall motion. No patients suffered serious side effects such as arrhythmias or hypotension. Studies were complete in all 26 patients. One study proved positive, with a new abnormality of wall motion identified corresponding to a critical right coronary arterial stenosis. Peak heart rate and blood pressure were similar for the 2 groups. High dose dobutamine stress echocardiography, therefore, is feasible and safe in children, and may detect flow-limiting coronary arterial stenoses noninvasively. The technique may safely be applied to other subsets of children where assessment of ischemia and contractile reserve is warranted.